Influenza News and Research

Latest Influenza News and Research

FDA issues final guidance to help develop safe and effective cell-based viral vaccines

The U.S. Food and Drug Administration today issued final guidance to help manufacturers who are developing safe and effective cell-based viral vaccines to address emerging and pandemic threats.

3 Mar 2010

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and the Netherlands Vaccine Institute announce today the launch of their joint AmpVacs project aiming at the development of a broadly protective synthetic influenza A vaccine component that in combination with classical antibody-stimulating vaccines will induce protection against future influenza A threats.

2 Mar 2010

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

The Greffex Group of regenerative medicine companies announces the signing of a Strategic Alliance Framework Agreement with UPMC and ISMETT, Italy.

2 Mar 2010

Stress increases resistance to influenza infection

A new study using mice suggests that a repeated stressful situation that triggers the animals' natural "fight-or-flight" response may actually enhance their ability to fight disease when re-exposed to the same pathogen.

2 Mar 2010

Intercell AG's revenues for full year 2009 increase 10.6%

Today, the biotech-vaccine company Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2009, and presented an update on the Company's development programs.

2 Mar 2010

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.

2 Mar 2010

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it.

2 Mar 2010

McGill University and RI MUHC secure $300,000 CIHR grant to develop VLP vaccines

The Canadian Institutes of Health Research (CIHR) have awarded a $300,000 grant for research focusing on the nature of the immune response induced by the action mechanisms of plant-made Virus-Like Particles (VLP) to Dr. Louis Vezina, Chief Scientific Officer of Medicago and to Dr. Brian Ward and Dr. Ciriaco Piccirillo of the Research Institute of the McGill University Health Centre (RI MUHC) and McGill University.

1 Mar 2010

Unexplained, sudden anemia: Brown recluse spider bite

As spring approaches and people return to outdoor activities, caution should be taken in areas of the country that are home to Loxosceles reclusa, also called the brown recluse spider. A new study from St. Jude Children's Research Hospital found that when patients present with sudden anemia, but the cause is elusive, the brown recluse spider should be part of the differential diagnosis, at least in parts of the nation where the spider is regularly found.

27 Feb 2010

Hygafem announces name change to WellBeing

Hygafem, the Georgia-based premier provider of full-service hygiene technologies, announced today that the company has changed its name to WellBeing. WellBeing is introducing a new and evolving touch-free hygiene and organizational wellness platform that communicates the company’s ongoing commitment to “green” hygiene services, excellence and innovation.

27 Feb 2010

Widespread cases of flu plunge from 49 to zero

Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year.

27 Feb 2010

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The “GreenVax Project” will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.

27 Feb 2010

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.

25 Feb 2010

Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production

25 Feb 2010

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

Families Fighting Flu (FFF) fully supports today's vote by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) to expand the current influenza vaccination recommendations to include all adults aged 19 to 49 years of age. Previous recommendations included all other age groups with the exception of this new adult population. This new recommendation will be implemented beginning with the 2010-2011 influenza season.

25 Feb 2010

American Lung Association supports ACIP's recommendations for universal influenza immunization

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' (ACIP) vote today that recommends universal influenza immunization with seasonal influenza vaccine.

25 Feb 2010

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.

25 Feb 2010

Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC

Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.

24 Feb 2010

FDA recommends H1N1 for inclusion in next year's flu vaccine

The U.S. Food and Drug Administration (FDA) on Monday recommended that the H1N1 (swine flu) strain be added to next year's seasonal flu vaccine, "putting an end to separate shots deployed against the pandemic," Bloomberg reports. The FDA committee voted unanimously to make the H1N1 strain one of the three strains included in the shot, according to the news service. "The panel's recommendations are routinely adopted and used to guide vaccine manufacturers," Bloomberg writes (Randall, 2/22).

24 Feb 2010

NanoViricides files quarterly report with Securities and Exchange Commission

NanoViricides, Inc. has filed its quarterly report with the Securities and Exchange Commission yesterday in a timely fashion.

24 Feb 2010

Influenza News and Research

Latest Influenza News and Research

FDA issues final guidance to help develop safe and effective cell-based viral vaccines

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

Stress increases resistance to influenza infection

Intercell AG's revenues for full year 2009 increase 10.6%

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

McGill University and RI MUHC secure $300,000 CIHR grant to develop VLP vaccines

Unexplained, sudden anemia: Brown recluse spider bite

Hygafem announces name change to WellBeing

Widespread cases of flu plunge from 49 to zero

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

American Lung Association supports ACIP's recommendations for universal influenza immunization

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC

FDA recommends H1N1 for inclusion in next year's flu vaccine

NanoViricides files quarterly report with Securities and Exchange Commission

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Influenza News and Research

Latest Influenza News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in